Equities research analysts expect Nextgen Healthcare Inc (NASDAQ:NXGN) to report sales of $133.47 million for the current fiscal quarter, according to Zacks. Ten analysts have provided estimates for Nextgen Healthcare’s earnings, with the highest sales estimate coming in at $135.87 million and the lowest estimate coming in at $130.90 million. Nextgen Healthcare posted sales of $135.78 million in the same quarter last year, which suggests a negative year-over-year growth rate of 1.7%. The business is expected to announce its next earnings results on Thursday, May 23rd.
According to Zacks, analysts expect that Nextgen Healthcare will report full year sales of $527.01 million for the current year, with estimates ranging from $525.30 million to $530.00 million. For the next financial year, analysts expect that the company will post sales of $554.94 million, with estimates ranging from $550.00 million to $560.10 million. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Nextgen Healthcare.
Nextgen Healthcare (NASDAQ:NXGN) last released its earnings results on Wednesday, January 23rd. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. The company had revenue of $130.87 million during the quarter, compared to the consensus estimate of $130.79 million. Nextgen Healthcare had a return on equity of 10.66% and a net margin of 1.80%.
Shares of Nextgen Healthcare stock traded down $0.07 on Monday, reaching $18.05. 128,000 shares of the company were exchanged, compared to its average volume of 233,578. Nextgen Healthcare has a 1-year low of $13.17 and a 1-year high of $23.73. The company has a market cap of $1.17 billion, a PE ratio of 31.67, a P/E/G ratio of 2.98 and a beta of 1.15. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.31 and a current ratio of 1.32.
Institutional investors have recently made changes to their positions in the company. PNC Financial Services Group Inc. boosted its holdings in Nextgen Healthcare by 37.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 2,387 shares of the company’s stock valued at $36,000 after purchasing an additional 649 shares in the last quarter. Quantamental Technologies LLC acquired a new position in Nextgen Healthcare in the fourth quarter valued at approximately $60,000. BlueMountain Capital Management LLC acquired a new position in Nextgen Healthcare in the third quarter valued at approximately $205,000. Quantbot Technologies LP acquired a new position in Nextgen Healthcare in the third quarter valued at approximately $207,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new position in Nextgen Healthcare in the third quarter valued at approximately $228,000. 71.64% of the stock is owned by institutional investors and hedge funds.
Nextgen Healthcare Company Profile
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Read More: How a Put Option Works
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.